Andersons pediatric cardiology 2348
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (101.67 KB, 3 trang )
selectivescreeningversusuniversalscreeningfor,1541
Dysphagia,vascularringsand,888
Dyssynchrony,ofleftventricularfunction,1196,1196f
Dystrophingene(DMD),78
E
Earlymyocardialdevelopment,59–62
atrialandventricularseptationin,60–61
atrioventricularvalvesformationin,61
cardiacloopingin,59–60,60f
humanandmouse,comparisonof,61,62f
outflowtractandsemilunarvalvedevelopmentin,61
structuralheartdiseaseoriginin,61–62
Earlytargetedtherapy,forhemodynamicallysignificantarterialduct,199
Ebsteinanomaly,318t
indiagnosticcatheterization,246
fetal,118–119
Ebsteinmalformation,585–590,586f
anatomyof,585–590,586f–589f
angiocardiographyin,596–597
cardiaccatheterizationin,596
causationof,589–590
chestradiographyin,592,593f
clinicalpresentationof,591,591t
definitionof,585
echocardiographyin,592–595,593f–597f
electrocardiographyin,591–592,592f
exercisetestingin,595
geneticsof,589–590
hemodynamicsin,596
medicaltreatmentof,598
morphogenesisof,590
naturalhistoryof,597–598
pathophysiologyof,590–601
physicalfindingsin,591
inpregnancy,1446
pregnancyand,598
prenataldetectionof,595,597f
surgicaltreatmentof,598–599
Echocardiography
anatomyprinciplesof,288–289,288f–289f
ofanomaliesoftheaorticarch,889,890f–891f
ofanomalousaorticoriginofacoronaryartery,873–874,874f
inarrhythmias,358
incancertherapy-relatedcardiotoxicity,1170
incardiactumors,967–968,967f–968f
chronicrheumaticheartdiseaseand,1027–1031
aorticvalvedisease,1027–1030,1030b,1031f
cardiosurgicalintervention,1031,1032f
mitralvalvedisease,1027,1028f–1030f,1028b
progression/resolutionmonitoring,1031
pulmonaryvalvedisease,1030
tricuspidvalvedisease,1030
valvularseveritygrading,1030–1031
incommonarterialtrunk,748–750,748f–750f
incongenitallymalformedhearts,inprematurity,208
contrast,301,301f
cross-sectional,126,285–286
onextracorporeallifesupport,1189,1190f,1190t
hemodynamicmeasurementsusing,305–306
meanpressuregradient,306,306f
inhemodynamicallysignificantarterialduct,197–198,197f
Kawasakisyndromeand,984–986,985f–986f,985b,986t
M-mode,285
inmyocarditis,1174–1175,1176f
normalcardiacanatomyon,286–300,286f–288f
postoperative,300–301,301f
duringpregnancy,1441–1442
ofpulmonaryarterialsling,892–893,894f
forpulmonaryhypertension,205,1387
inpulmonarystenosis,782–785,782f–784f
quantitative,302–305
storageandreportingofimagescreatedin,286
stress,301,398
insuddencardiacdeath,1537–1538
oftelemedicineinpediatriccardiology,1553–1555,1554t
Echo-tracking,1362,1363f
ECLS,Extracorporeallifesupport
ECMO,Extracorporealmembraneoxygenation
Ectoderm,33,34f
Ectopiacordis,913–915,914f–915f
Education,duringtransition,1453
EdwardsSapienXTTranscatheterHeartValve,259
Effusions,inmodifiedFontanprocedure,1304
Ehlers-Danlossyndrome,cardiacinvolvementin,1079–1080,1098
Eisenmengersyndrome
atrioventricularseptaldefectsand,534–535
indiagnosticcatheterization,248
Ejectionfraction,101,326
Elasticfibers,1355–1356
Elastin,arteriesand,1355–1356
Elastingene(ELN),1412
Electroanatomicmapping,oftachycardia,360,362f
Electrocardiographicrecorders,forexercisetesting,388
Electrocardiography
inarrhythmias,357
incancertherapy-relatedcardiotoxicity,1170
incardiactumors,966
